{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:43:30Z","timestamp":1789238610061,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007114","name":"Ralph W and Grace M Showalter Research Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmc.2021.116129","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T21:20:42Z","timestamp":1618867242000},"page":"116129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Exploiting the HSP60\/10 chaperonin system as a chemotherapeutic target for colorectal cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"Anne-Marie","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilshad","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mckayla","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi","family":"Chitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanofar","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Sivinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-5088","authenticated-orcid":false,"given":"Heather M.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-4128","authenticated-orcid":false,"given":"Steven M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116129_b0005","unstructured":"Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Pineros, M.; Znaor, A.; Soerjomataram, I.; Bray, F. Cancer Today (powered by GLOBOCAN 2018) http:\/\/publications.iarc.fr\/Databases\/Iarc-Cancerbases\/Cancer-Today-Powered-By-GLOBOCAN-2018--2018 (accessed Jul 11, 2019)."},{"key":"10.1016\/j.bmc.2021.116129_b0010","series-title":"SEER Cancer Statistics Review 1975\u20132016","author":"Howlander","year":"2019"},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat Shock Proteins and Cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cells9010060","article-title":"Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy","volume":"9","author":"Yun","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","article-title":"Guidelines for the Nomenclature of the Human Heat Shock Proteins","volume":"14","author":"Kampinga","year":"2009","journal-title":"Cell Stress Chaperones"},{"issue":"9","key":"10.1016\/j.bmc.2021.116129_b0030","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3390\/ijms18091978","article-title":"Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach","volume":"18","author":"Chatterjee","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2014.2399","article-title":"HSP27, 70 and 90, Anti-Apoptotic Proteins, in Clinical Cancer Therapy (Review)","volume":"45","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.bmc.2021.116129_b0040","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2005.12.085","article-title":"Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors","volume":"23","author":"Grem","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clml.2013.03.010","article-title":"Phase i Trial of the HSP90 Inhibitor PF-04929113 (SNX5422) in Adult Patients with Recurrent, Refractory Hematologic Malignancies","volume":"13","author":"Reddy","year":"2013","journal-title":"Clin. Lymphoma, Myeloma Leuk."},{"issue":"21","key":"10.1016\/j.bmc.2021.116129_b0050","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/1078-0432.CCR-11-0821","article-title":"A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas","volume":"17","author":"Rajan","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4155\/fmc.14.154","article-title":"Heat-Shock Protein 90 Inhibitors: Will They Ever Succeed as Chemotherapeutics?","volume":"7","author":"Wang","year":"2015","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ctrv.2012.10.001","article-title":"Targeting the Molecular Chaperone Heat Shock Protein 90 (HSP90): Lessons Learned and Future Directions","volume":"39","author":"Hong","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bmc.2021.116129_b0065","first-page":"289","article-title":"HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact; Springer","author":"Proia","year":"2015","journal-title":"Cham"},{"issue":"22","key":"10.1016\/j.bmc.2021.116129_b0070","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1158\/0008-5472.CAN-06-1629","article-title":"Up-Regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism","volume":"66","author":"McCollum","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0080","first-page":"42","article-title":"A Phase I and Pharmacokinetic Study of the Mitochondrial-Specific Rhodacyanine Dye Analog MKT 077","volume":"6","author":"Britten","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bmc.2021.116129_b0085","first-page":"371","article-title":"Hsp70: A Cancer Target inside and Outside the Cell","volume":"Vol. 1709","author":"Boudesco","year":"2018"},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10637-017-0553-x","article-title":"A Randomized Phase 2 Study of a HSP27 Targeting Antisense, Apatorsen with Prednisone versus Prednisone Alone, in Patients with Metastatic Castration Resistant Prostate Cancer","volume":"36","author":"Yu","year":"2018","journal-title":"Invest. New Drugs"},{"issue":"7","key":"10.1016\/j.bmc.2021.116129_b0095","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1021\/mp300167e","article-title":"Rational Development of a Cytotoxic Peptide to Trigger Cell Death","volume":"9","author":"Boohaker","year":"2012","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.bmc.2021.116129_b0100","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/1078-0432.CCR-15-2502","article-title":"Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide","volume":"22","author":"Bassiouni","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"66","key":"10.1016\/j.bmc.2021.116129_b0105","doi-asserted-by":"crossref","first-page":"110273","DOI":"10.18632\/oncotarget.22681","article-title":"Targeting Chaperonin Containing TCP1 (CCT) as a Molecular Therapeutic for Small Cell Lung Cancer","volume":"8","author":"Carr","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bmc.2021.116129_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.225","article-title":"The CT20 Peptide Causes Detachment and Death of Metastatic Breast Cancer Cells by Promoting Mitochondrial Aggregation and Cytoskeletal Disruption","volume":"5","author":"Lee","year":"2014","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.bmc.2021.116129_b0115","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.febslet.2015.06.019","article-title":"Dynamics, Flexibility, and Allostery in Molecular Chaperonins","volume":"589","author":"Skj\u00e6rven","year":"2015","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bmc.2021.116129_b0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/cncr.11594","article-title":"Heat Shock Proteins HSP27, HSP60, HSP70, and HSP90","volume":"98","author":"Lebret","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12192-015-0646-4","article-title":"CD1A-Positive Cells and HSP60 (HSPD1) Levels in Keratoacanthoma and Squamous Cell Carcinoma","volume":"21","author":"Cabibi","year":"2016","journal-title":"Cell Stress Chaperones"},{"issue":"25","key":"10.1016\/j.bmc.2021.116129_b0130","doi-asserted-by":"crossref","first-page":"38822","DOI":"10.18632\/oncotarget.9615","article-title":"Downregulation of HSP60 Disrupts Mitochondrial Proteostasis to Promote Tumorigenesis and Progression in Clear Cell Renal Cell Carcinoma","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2021.116129_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-5-64","article-title":"Pathway Analysis of Kidney Cancer Using Proteomics and Metabolic Profiling","volume":"5","author":"Perroud","year":"2006","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bmc.2021.116129_b0140","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1074\/mcp.M900168-MCP200","article-title":"Systematic Comparative Protein Expression Profiling of Clear Cell Renal Cell Carcinoma: A Pilot Study Based on the Separation of Tissue Specimens by Two-Dimensional Gel Electrophoresis","volume":"8","author":"Lichtenfels","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"issue":"8","key":"10.1016\/j.bmc.2021.116129_b0145","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/pr800389e","article-title":"Differential Protein Expressions in Renal Cell Carcinoma: New Biomarker Discovery by Mass Spectrometry","volume":"8","author":"Siu","year":"2009","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.1529","article-title":"Quantitative Proteomic Analysis Reveals Potential Diagnostic Markers and Pathways Involved in Pathogenesis of Renal Cell Carcinoma","volume":"5","author":"White","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0155","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2013.e20","article-title":"Different Immunohistochemical Levels of Hsp60 and Hsp70 in a Subset of Brain Tumors and Putative Role of Hsp60 in Neuroepithelial Tumorigenesis","volume":"57","author":"Rappa","year":"2013","journal-title":"Eur. J. Histochem."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/ijms20010131","article-title":"CCAR2\/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bmc.2021.116129_b0165","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1021\/pr800130d","article-title":"Proteomics-Based Identification of HSP60 as a Tumor-Associated Antigen in Early Stage Breast Cancer and Ductal Carcinoma in Situ","volume":"7","author":"Desmetz","year":"2008","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000067304","article-title":"Expression of 60-KD Heat Shock Protein Increases during Carcinogenesis in the Uterine Exocervix","volume":"70","author":"Cappello","year":"2002","journal-title":"Pathobiology"},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3349\/ymj.2009.50.3.399","article-title":"Expression of Heat Shock Protein 60 KDa Is Upregulated in Cervical Cancer","volume":"50","author":"Hwang","year":"2009","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2005.06.045","article-title":"Immunohistochemical Evaluation of Heat Shock Proteins in Normal and Preinvasive Lesions of the Cervix","volume":"229","author":"Castle","year":"2005","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bmc.2021.116129_b0185","article-title":"Heat Shock Protein 60 Overexpression Is Associated with the Progression and Prognosis in Gastric Cancer","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-230X-9-14","article-title":"Heat Shock Protein-27, -60 and -90 Expression in Gastric Cancer: Association with Clinicopathological Variables and Patient Survival","volume":"9","author":"Giaginis","year":"2009","journal-title":"BMC Gastroenterol."},{"issue":"24","key":"10.1016\/j.bmc.2021.116129_b0195","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1111\/j.1742-4658.2011.08385.x","article-title":"Identification and Verification of Heat Shock Protein 60 as a Potential Serum Marker for Colorectal Cancer","volume":"278","author":"Hamelin","year":"2011","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.bmc.2021.116129_b0200","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/pmic.200401196","article-title":"Proteomic Expression Analysis of Colorectal Cancer by Two-Dimensional Differential Gel Electrophoresis","volume":"5","author":"Alfonso","year":"2005","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/814","article-title":"60KDa Chaperonin (HSP60) Is over-Expressed during Colorectal Carcinogenesis","volume":"47","author":"Cappello","year":"2003","journal-title":"Eur. J. Histochem."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2407-5-139","article-title":"The Expression of Hsp60 and Hsp10 in Large Bowel Carcinomas with Lymph Node Metastases","volume":"5","author":"Cappello","year":"2005","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0215","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/prca.200600718","article-title":"Proteomics-Based Identification of HSP60 as a Tumor-Associated Antigen in Colorectal Cancer","volume":"1","author":"He","year":"2007","journal-title":"Proteomics. Clin. Appl."},{"issue":"5","key":"10.1016\/j.bmc.2021.116129_b0220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12192-016-0721-5","article-title":"Quantitative Patterns of Hsps in Tubular Adenoma Compared with Normal and Tumor Tissues Reveal the Value of Hsp10 and Hsp60 in Early Diagnosis of Large Bowel Cancer","volume":"21","author":"Rappa","year":"2016","journal-title":"Cell Stress Chaperones"},{"issue":"18","key":"10.1016\/j.bmc.2021.116129_b0225","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/cncr.29499","article-title":"Heat Shock Protein 60 Levels in Tissue and Circulating Exosomes in Human Large Bowel Cancer before and after Ablative Surgery","volume":"121","author":"Campanella","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bmc.2021.116129_b0230","first-page":"6284","article-title":"Novel Serum Markers HSP60, CHI3L1, and IGFBP-2 in Metastatic Colorectal Cancer","volume":"18","author":"Vocka","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bmc.2021.116129_b0235","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/carcin\/bgp087","article-title":"Interaction between HSP60 and Beta-Catenin Promotes Metastasis","volume":"30","author":"Tsai","year":"2009","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.oraloncology.2005.06.017","article-title":"Immunohistochemical Analysis of P57(Kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues","volume":"42","author":"Fan","year":"2006","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0245","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1038\/s41598-019-45489-1","article-title":"HSPD1 Repressed E-Cadherin Expression to Promote Cell Invasion and Migration for Poor Prognosis in Oral Squamous Cell Carcinoma","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bmc.2021.116129_b0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21992","article-title":"Heat Shock Protein-60 Expression Was Significantly Correlated with the Prognosis of Lung Adenocarcinoma","volume":"104","author":"Xu","year":"2011","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00686173","article-title":"Regulation of HSP60 MRNA Expression in a Human Ovarian Carcinoma Cell Line","volume":"32","author":"Kimura","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/j.bmc.2021.116129_b0260","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/IGC.0000000000000246","article-title":"Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites","volume":"24","author":"Hjerpe","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0265","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/IGC.0b013e318284308b","article-title":"HSP60 Predicts Survival in Advanced Serous Ovarian Cancer","volume":"23","author":"Hjerpe","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-017-0196-z","article-title":"Oncogenic HSP60 Regulates Mitochondrial Oxidative Phosphorylation to Support Erk1\/2 Activation during Pancreatic Cancer Cell Growth","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis."},{"issue":"24","key":"10.1016\/j.bmc.2021.116129_b0275","first-page":"7099","article-title":"Heat Shock Protein Expression Independently Predicts Clinical Outcome in Prostate Cancer","volume":"60","author":"Cornford","year":"2000","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bmc.2021.116129_b0280","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/pros.20453","article-title":"Proteomic Comparison of Prostate Cancer Cell Lines LNCaP-FGC and LNCaP-r Reveals Heatshock Protein 60 as a Marker for Prostate Malignancy","volume":"66","author":"Johansson","year":"2006","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.bmc.2021.116129_b0285","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-0463.2008.01051.x","article-title":"Heat Shock Proteins 27, 60 and 70 as Prognostic Markers of Prostate Cancer","volume":"116","author":"Glaessgen","year":"2008","journal-title":"Apmis"},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0290","doi-asserted-by":"crossref","first-page":"1017.e1","DOI":"10.1016\/j.urology.2010.05.045","article-title":"Immunohistochemical Expression of Hsp60 Correlates with Tumor Progression and Hormone Resistance in Prostate Cancer","volume":"76","author":"Castilla","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/pr100921j","article-title":"Proteomics Profiling of Microdissected Low- and High-Grade Prostate Tumors Identifies Lamin A as a Discriminatory Biomarker","volume":"10","author":"Skvortsov","year":"2011","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.bmc.2021.116129_b0300","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pros.23537","article-title":"Differential Expression of Annexin 2, SPINK1, and Hsp60 Predict Progression of Prostate Cancer through Bifurcated WHO Gleason Score Categories in African American Men","volume":"78","author":"Beyene","year":"2018","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.bmc.2021.116129_b0305","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4161\/cbt.7.6.6281","article-title":"Hsp60 Expression, New Locations, Functions and Perspectives for Cancer Diagnosis and Therapy","volume":"7","author":"Cappello","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.bmc.2021.116129_b0310","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/1440-1681.12457","article-title":"HSP60 Overexpression Increases the Protein Levels of the P110\u03b1 Subunit of Phosphoinositide 3-Kinase and c-Myc","volume":"42","author":"Yan","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009422","article-title":"Cytosolic Hsp60 Is Involved in the NF-KappaB-Dependent Survival of Cancer Cells via IKK Regulation","volume":"5","author":"Chun","year":"2010","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bmc.2021.116129_b0320","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1074\/jbc.M705904200","article-title":"Hsp60 Regulation of Tumor Cell Apoptosis","volume":"283","author":"Ghosh","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cells9010023","article-title":"Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells","volume":"9","author":"Huang","year":"2019","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.bmc.2021.116129_b0330","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1158\/0008-5472.CAN-10-2225","article-title":"Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells","volume":"70","author":"Ghosh","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bmc.2021.116129_b0335","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.99","article-title":"The Tumour-Suppressive Function of CLU Is Explained by Its Localisation and Interaction with HSP60","volume":"2","author":"Chaiwatanasirikul","year":"2011","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bmc.2021.116129_b0340","first-page":"1541","article-title":"Identification of Heat Shock Protein 60 as a Molecular Mediator of Alpha 3 Beta 1 Integrin Activation","volume":"62","author":"Barazi","year":"2002","journal-title":"Cancer Res."},{"issue":"34","key":"10.1016\/j.bmc.2021.116129_b0345","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1021\/ja104739t","article-title":"Identification of HSP60 as a Primary Target of O-Carboranylphenoxyacetanilide, an HIF-1alpha Inhibitor","volume":"132","author":"Ban","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"15","key":"10.1016\/j.bmc.2021.116129_b0350","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/sj.onc.1207398","article-title":"Identification of NPM-ALK Interacting Proteins by Tandem Mass Spectrometry","volume":"23","author":"Crockett","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2021.116129_b0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fmolb.2018.00035","article-title":"Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics","volume":"5","author":"Meng","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.bmc.2021.116129_b0360","first-page":"775","article-title":"Studies on Bredinin","volume":"27","author":"Mizuno","year":"1974","journal-title":"I. Isolation, Characterization and Biological Properties. J. Antibiot. (Tokyo)"},{"issue":"49","key":"10.1016\/j.bmc.2021.116129_b0365","doi-asserted-by":"crossref","first-page":"35147","DOI":"10.1074\/jbc.274.49.35147","article-title":"Mammalian HSP60 Is a Major Target for an Immunosuppressant Mizoribine","volume":"274","author":"Itoh","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"02","key":"10.1016\/j.bmc.2021.116129_b0370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4236\/ajmb.2012.22010","article-title":"The ATPase Activity of Molecular Chaperone HSP60 Is Inhibited by Immunosuppressant Mizoribine","volume":"02","author":"Tanabe","year":"2012","journal-title":"Am. J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bmc.2021.116129_b0375","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7164\/antibiotics.48.733","article-title":"Epolactaene, a Novel Neuritogenic Compound in Human Neuroblastoma Cells, Produced by a Marine Fungus","volume":"48","author":"Kakeya","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0380","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/BJ20041355","article-title":"Epolactaene Binds Human Hsp60 Cys442 Resulting in the Inhibition of Chaperone Activity","volume":"387","author":"Nagumo","year":"2005","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.bmc.2021.116129_b0385","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s10495-015-1170-9","article-title":"The Acylphloroglucinols Hyperforin and Myrtucommulone A Cause Mitochondrial Dysfunctions in Leukemic Cells by Direct Interference with Mitochondria","volume":"20","author":"Wiechmann","year":"2015","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.bmc.2021.116129_b0390","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.chembiol.2017.04.008","article-title":"Mitochondrial Chaperonin HSP60 Is the Apoptosis-Related Target for Myrtucommulone","volume":"24","author":"Wiechmann","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bmc.2021.116129_b0395","article-title":"Avrainvillamide, a Cytotoxic Marine Natural Product, and Derivatives Thereof - Patent US-6066635-A - PubChem","author":"Fenical","year":"2000","journal-title":"US6066635A"},{"issue":"16","key":"10.1016\/j.bmc.2021.116129_b0400","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1021\/ja0690971","article-title":"Evidence for the Rapid Conversion of Stephacidin B into the Electrophilic Monomer Avrainvillamide in Cell Culture","volume":"129","author":"Wulff","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0405","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bmcl.2009.12.037","article-title":"Boron-Containing Phenoxyacetanilide Derivatives as Hypoxia-Inducible Factor (HIF)-1alpha Inhibitors","volume":"20","author":"Shimizu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bmc.2021.116129_b0410","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/anie.201509612","article-title":"Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60","volume":"55","author":"Hu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.bmc.2021.116129_b0415","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bmcl.2013.12.100","article-title":"A Biochemical Screen for GroEL\/GroES Inhibitors","volume":"24","author":"Johnson","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bmc.2021.116129_b0420","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.bmcl.2016.04.089","article-title":"GroEL\/ES Inhibitors as Potential Antibiotics","volume":"26","author":"Abdeen","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bmc.2021.116129_b0425","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1021\/acs.jmedchem.8b00989","article-title":"Sulfonamido-2-Arylbenzoxazole GroEL\/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus Aureus (MRSA)","volume":"61","author":"Abdeen","year":"2018","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bmc.2021.116129_b0430","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1021\/acs.jmedchem.8b01293","article-title":"Hydroxybiphenylamide GroEL\/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus Aureus","volume":"61","author":"Kunkle","year":"2018","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bmc.2021.116129_b0435","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.bmcl.2016.09.051","article-title":"Targeting the HSP60\/10 Chaperonin Systems of Trypanosoma Brucei as a Strategy for Treating African Sleeping Sickness","volume":"26","author":"Abdeen","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bmc.2021.116129_b0440","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41467-020-15698-8","article-title":"Structural Basis for Active Single and Double Ring Complexes in Human Mitochondrial Hsp60-Hsp10 Chaperonin","volume":"11","author":"Gomez-Llorente","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bmc.2021.116129_b0445","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0006-291X(90)90344-M","article-title":"Mitochondrial Import of the Human Chaperonin (HSP60) Protein","volume":"169","author":"Singh","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"43","key":"10.1016\/j.bmc.2021.116129_b0450","doi-asserted-by":"crossref","first-page":"31289","DOI":"10.1074\/jbc.M702777200","article-title":"Cytosolic Accumulation of HSP60 during Apoptosis with or without Apparent Mitochondrial Release: Evidence That Its pro-Apoptotic or pro-Survival Functions Involve Differential Interactions with Caspase-3","volume":"282","author":"Chandra","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bmc.2021.116129_b0455","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bmcl.2019.04.034","article-title":"Dual-Targeting GroEL\/ES Chaperonin and Protein Tyrosine Phosphatase B (PtpB)Inhibitors: A Polypharmacology Strategy for Treating Mycobacterium Tuberculosis Infections","volume":"29","author":"Washburn","year":"2019","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bmc.2021.116129_b0460","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bmcl.2019.02.028","article-title":"HSP60\/10 Chaperonin Systems Are Inhibited by a Variety of Approved Drugs, Natural Products, and Known Bioactive Molecules","volume":"29","author":"Stevens","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:19Z","timestamp":1760836459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":92,"alternative-id":["S0968089621001371"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116129","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting the HSP60\/10 chaperonin system as a chemotherapeutic target for colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116129"}}